SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

BMO Capital Maintains Outperform on Aptinyx, Lowers Price Target to $13

BMO Capital maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $15 to $13.

Benzinga · -

BMO Capital maintains Aptinyx (NASDAQ:APTX) with a Outperform and lowers the price target from $15 to $13.